drugset / Trial / NCT06620939
The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence
Not yet recruiting
558 enrolled
Zhang Jian
Nanjing Maternity and Child Health Care Hospital · collabRenJi Hospital · collabShanghai First Maternal and Infant Health Hospital affiliated to Tongji University Medical School · collabShanghai General Hospital, Shanghai Jiao Tong University School of Medicine · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The goal of this clinical trial is to determine whether the LNG-IUS is more effective to that of expectant in preventing endometrial polyp recurrence after hysteroscopic polypectomy. Researchers will compare LNG-IUS to expectant management to see if LNG-IUS works to reduce the recurrence rate of endometrial polyps. Participants will: Receive Mirena placement or not after hysteroscopic polypectomy； Be scheduled for a follow-up with TVCD to screen for endometrial polyps recurrence every 6 months.
Timeline
- Start
- 2024-12-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | — | Other |